Fostamatinib is a selective spleen tyrosine kinase (SYK) inhibitor indicated for the treatment of chronic immune thrombocytopenia in adult patients. By modulating immune cell activity and inhibiting signal… Read more
![Chemical structure of (2S,3S,4S,5R,6R)-6-(6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1293999-42-4-2S3S4S5R6R-6-6-5-Fluoro-2-345-trimethoxyphenylaminopyrimidin-4-ylamino-22-dimethyl-3-oxo-23-dihydro-4H-pyrido32-b14oxazin-4-yl-345-trihyd.png&w=3840&q=75)
![Chemical structure of (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6-5-Fluoro-2-345-trimethoxyphenylaminopyrimidin-4-ylnitrosoamino-22-dimethyl-3-oxo-23-dihydro-4H-pyrido32-b14oxazin-4-ylmethyl-dihydrogen-phosphate.png&w=3840&q=75)
![Chemical structure of (6-((5-Fluoro-2-(nitroso(3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6-5-Fluoro-2-nitroso345-trimethoxyphenylaminopyrimidin-4-ylnitrosoamino-22-dimethyl-3-oxo-23-dihydro-4H-pyrido32-b14oxazin-4-ylmethyl-dihydrogen-phosp.png&w=3840&q=75)
![Chemical structure of (6-((5-Fluoro-2-(nitroso(3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6-5-Fluoro-2-nitroso345-trimethoxyphenylaminopyrimidin-4-ylamino-22-dimethyl-3-oxo-23-dihydro-4H-pyrido32-b14oxazin-4-ylmethyl-dihydrogen-phosphate.png&w=3840&q=75)
![Chemical structure of 2,2-Dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F20348-21-4-22-Dimethyl-2H-pyrido32-b14oxazin-34H-one.png&w=3840&q=75)
![Chemical structure of 2,2-Dimethyl-6-nitro-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1002726-59-1-22-Dimethyl-6-nitro-2H-pyrido32-b14oxazin-34H-one.png&w=3840&q=75)
![Chemical structure of 4,4'-Methylenebis(6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F44-Methylenebis6-5-fluoro-2-345-trimethoxyphenylaminopyrimidin-4-ylamino-22-dimethyl-2H-pyrido32-b14oxazin-34H-one.png&w=3840&q=75)
![Chemical structure of 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F841290-80-0-6-5-fluoro-2-345-trimethoxyphenylaminopyrimidin-4-ylamino-22-dimethyl-2H-pyrido32-b14oxazin-34H-one.png&w=3840&q=75)
![Chemical structure of 6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-4-(hydroxymethyl)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F901119-39-9-6-5-Fluoro-2-345-trimethoxyphenylaminopyrimidin-4-ylamino-4-hydroxymethyl-22-dimethyl-2H-pyrido32-b14oxazin-34H-one.png&w=3840&q=75)
![Chemical structure of 6-((5-Fluoro-2-((4-hydroxy-3,5-dimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1294007-59-2-6-5-Fluoro-2-4-hydroxy-35-dimethoxyphenylaminopyrimidin-4-ylamino-22-dimethyl-2H-pyrido32-b14oxazin-34H-one.png&w=3840&q=75)

![Chemical structure of di-tert-Butyl ((6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl) phosphate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F901119-38-8-di-tert-Butyl-6-5-fluoro-2-345-trimethoxyphenylaminopyrimidin-4-ylamino-22-dimethyl-3-oxo-23-dihydro-4H-pyrido32-b14oxazin-4-ylmethyl-phos.png&w=3840&q=75)


















![Chemical structure of tert-Butyl ((6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl) hydrogen phosphate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-6-5-fluoro-2-345-trimethoxyphenylaminopyrimidin-4-ylamino-22-dimethyl-3-oxo-23-dihydro-4H-pyrido32-b14oxazin-4-ylmethyl-hydrogen-phosphate.png&w=3840&q=75)
Fostamatinib is a selective spleen tyrosine kinase (SYK) inhibitor indicated for the treatment of chronic immune thrombocytopenia in adult patients. By modulating immune cell activity and inhibiting signal transduction pathways that drive platelet destruction, this medication helps manage autoimmune responses. Pharmaceutical laboratories rely on accurate reference standards of Fostamatinib and its related compounds to maintain rigorous quality control. This collection includes critical materials for impurity profiling, such as synthetic process-related impurities and drug metabolites, which are essential for identifying and quantifying potential degradation products. Furthermore, stable isotope labelled compounds, such as deuterium and carbon-13 variants, serve as internal standards for mass spectrometry applications. These high-quality materials support comprehensive analytical method validation, ensuring precision and reliability in both pharmacokinetic studies and routine regulatory testing throughout the development lifecycle of the therapeutic agent.